GCVAX
Price
$23.01
Change
-$0.66 (-2.79%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GCVAX vs RMFCX

Header iconGCVAX vs RMFCX Comparison
Open Charts GCVAX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts A
Price$23.01
Change-$0.66 (-2.79%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GCVAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCVAX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVAX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GCVAX (508M). RMFCX pays higher dividends than GCVAX: RMFCX (1.69) vs GCVAX (1.02). GCVAX was incepted earlier than RMFCX: GCVAX (26 years) vs RMFCX (23 years). GCVAX is a more actively managed with annual turnover of: 208.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GCVAX: RMFCX (250) vs GCVAX (1000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GCVAX (7.64). RMFCX return over 5 years is better than : 40.39 vs. GCVAX (12.37).
GCVAXRMFCXGCVAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD6.54111.42357%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets508M98.7B1%
Annual Yield % from dividends1.021.6960%
Returns for 1 year7.6412.6360%
Returns for 3 years6.6814.1647%
Returns for 5 years12.3740.3931%
Returns for 10 years50.6861.8482%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc